VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

BioAge Labs, Inc. (BIOA) Total Return Calculator with Dividends Reinvested

BioAge Labs, Inc.

Popular:

The total return for BioAge Labs, Inc. (BIOA) stock is +367.34% over the past 12 months. So far it's up 43.88% this year. The 5-year total return is +0.82%, meaning $10,000 invested in BIOA stock 5 years ago would be worth $10,082 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in BIOA 1 year ago, it would be worth $45,468 today — you'd have gained $35,468.

With Dividends Reinvested$45,468+354.68%

Price Only (No DRIP)$45,468+354.68%

Period2025-05-07 → 2026-05-06

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in BIOA

1Y$46,734+$36,734 (+367.3%)367.3% CAGR

3Y$10,082+$82 (+0.8%)0.3% CAGR

5Y$10,082+$82 (+0.8%)0.2% CAGR

10Y$10,082+$82 (+0.8%)0.1% CAGR

15Y$10,082+$82 (+0.8%)0.1% CAGR

20Y$10,082+$82 (+0.8%)0.0% CAGR

30Y$10,082+$82 (+0.8%)0.0% CAGR

BioAge Labs, Inc. did not pay dividends during this period. Total return = price return.

Loading BIOA total return...

As of 2026-05-07

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	+43.88%	—	+43.88%	—	$14,388
1Y	+367.34%	367.34%	+367.34%	—	$46,734
3Y	+0.82%	0.27%	+0.82%	—	$10,082
5Y	+0.82%	0.16%	+0.82%	—	$10,082
10Y	+0.82%	0.08%	+0.82%	—	$10,082
15Y	+0.82%	0.05%	+0.82%	—	$10,082
20Y	+0.82%	0.04%	+0.82%	—	$10,082
30Y	+0.82%	0.03%	+0.82%	—	$10,082

Risk & Highlights

Best Year+137.95%2025

Worst Year-68.38%2024

Max Drawdown-30.93%2026-01-14 → 2026-03-30

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	+73.58%	+73.58%	—	+0.41%	+73.2pp
2025	+137.95%	+137.95%	—	+16.64%	+121.3pp
2024	-68.38%	-68.38%	—	+24.00%	-92.4pp

BIOA outperformed the S&P 500 by 336.02pp over the past year (+367.34% vs +31.32%).

Loading summary...

BIOA Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
BIOABioAge Labs, Inc.	$664M	+5.3%	+43.9%	+367.3%	—	+0.8%	+0.8%	+0.8%
KYMRKymera Therapeutics, Inc.	$7.0B	+1.2%	+18.6%	+201.9%	—	+211.0%	+110.5%	+159.4%
RVMDRevolution Medicines, Inc.	$32.1B	+58.2%	+91.2%	+303.5%	—	+518.1%	+420.9%	+422.7%
LNTHLantheus Holdings, Inc.	$5.6B	+13.5%	+28.1%	-17.8%	—	-9.1%	+290.0%	+4002.4%
RYTMRhythm Pharmaceuticals, Inc.	$6.6B	+11.1%	-8.0%	+54.1%	—	+479.5%	+349.3%	+222.0%
VNDAVanda Pharmaceuticals Inc.	$440M	+6.7%	-9.8%	+70.3%	—	+7.4%	-57.5%	-13.6%
NUVLNuvalent, Inc.	$6.9B	+0.5%	+3.4%	+52.9%	—	+176.1%	+456.1%	+456.1%
IMVTImmunovant, Inc.	$5.8B	+15.2%	+10.7%	+107.2%	—	+48.4%	+73.9%	+188.1%
ARDXArdelyx, Inc.	$1.7B	+18.9%	+15.4%	+79.7%	—	+69.5%	+327.7%	+290.1%
LLYEli Lilly and Company	$932.6B	+6.5%	-8.5%	+28.2%	+0.8pp	+131.9%	+421.4%	+1271.7%
NVONovo Nordisk A/S	$203.4B	+24.8%	-10.2%	-28.2%	+2.8pp	-40.7%	+39.0%	+105.1%

Compare:BIOA vs KYMR BIOA vs RVMD BIOA vs LNTH BIOA vs KYMR vs RVMD

About BIOA Dividend Returns

BioAge Labs, Inc. (BIOA) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of BIOA over the past year?

BioAge Labs, Inc. (BIOA) delivered a return of 367.34% over the past year. Since BIOA does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in BIOA be worth today?

A $10,000 investment in BioAge Labs, Inc. one year ago would be worth $46,734 today, representing a gain of $36,734.

Q3Does BIOA pay dividends?

BioAge Labs, Inc. (BIOA) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For BIOA, the total return equals the price-only return.

Q4Did BIOA beat the S&P 500?

Yes, BioAge Labs, Inc. (BIOA) outperformed the S&P 500 by 336.02 percentage points over the past year. BIOA delivered a total return of 367.34%, compared to the S&P 500's 31.32%. This 336.02pp alpha means investors in BIOA earned more than a passive S&P 500 index fund.

Q5What is BIOA's worst drawdown?

BioAge Labs, Inc. (BIOA) experienced a maximum drawdown of -30.93% over the past year, declining from its peak on 2026-01-14 to its trough on 2026-03-30. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is BIOA's long-term total return over 10, 20, or 30 years?

Here are BioAge Labs, Inc. (BIOA)'s long-term returns with dividends reinvested. Over 10 years, the total return is 0.8% (0.1% CAGR) — $10,000 would have grown to $10,082. Over 20 years: 0.8% total return (0.0% CAGR) — $10,000 → $10,082. Over 30 years: 0.8% total return (0.0% CAGR) — $10,000 → $10,082. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was BIOA's best and worst year?

BioAge Labs, Inc.'s best calendar year was 2025 with a total return of 137.9%. Its worst year was 2024 with a total return of -68.4%. This range shows the volatility investors should expect — the difference between the best and worst year is 206.3 percentage points.